Pharming Group (PHAR) Institutional Ownership $13.70 +1.04 (+8.21%) Closing price 03:52 PM EasternExtended Trading$13.27 -0.43 (-3.14%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Pharming Group (NASDAQ:PHAR)CurrentInstitutional OwnershipPercentage0.03%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$291.21KNumber ofInstitutional Sellers(last 12 months)0 Get PHAR Insider Trade Alerts Want to know when executives and insiders are buying or selling Pharming Group stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PHAR Institutional Buying and Selling by Quarter Pharming Group Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/13/2025 EverSource Wealth Advisors LLC2,979$32K0.0%N/A0.004% 7/9/2025 Silverberg Bernstein Capital Management LLC52,147$557K0.4%+8.6%0.077% 1/14/2025 Silverberg Bernstein Capital Management LLC47,997$483K0.4%+16.8%0.071% 10/5/2024 Silverberg Bernstein Capital Management LLC41,110$339K0.3%+75.4%0.061% 7/12/2024 Silverberg Bernstein Capital Management LLC23,435$196K0.2%+32.3%0.035% 1/17/2024 Silverberg Bernstein Capital Management LLC17,710$202K0.2%N/A0.026% 11/1/2023Orion Portfolio Solutions LLC11,715$134K0.0%N/A0.018% 2/1/2023Cowen Prime Advisors LLC21,610$238K0.1%+29.4%0.033% 2/8/2022Cowen Prime Advisors LLC14,800$132K0.0%+134.9%0.023% 8/6/2021 JW Asset Management LLC169,225$1.91M0.4%-10.7%0.264% 8/4/2021Cowen Prime Advisors LLC6,300$71K0.0%N/A0.010% (Data available from 1/1/2016 forward) PHAR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PHAR shares? During the previous two years, the following institutional investors and hedge funds held shares of Pharming Group shares: Silverberg Bernstein Capital Management LLC ($557K), and Orion Portfolio Solutions LLC ($134K), EverSource Wealth Advisors LLC ($32K).Learn more on Pharming Group's institutional investors. What percentage of Pharming Group's stock is owned by institutional investors? 0.03% of Pharming Group's stock is owned by institutional investors. Learn more on PHAR's institutional investor holdings. Which institutional investors have been buying Pharming Group's stock? The following institutional investors have purchased Pharming Group's stock in the last 24 months: Silverberg Bernstein Capital Management LLC ($52.15K), Orion Portfolio Solutions LLC ($11.72K), and EverSource Wealth Advisors LLC ($2.98K). How much institutional buying is happening at Pharming Group? Institutional investors have bought a total of 31,691 shares in the last 24 months. This purchase volume represents approximately $291.21K in transactions. Related Companies PTCT Institutional Ownership MLTX Institutional Ownership MTSR Institutional Ownership PTGX Institutional Ownership APLS Institutional Ownership SRRK Institutional Ownership MIRM Institutional Ownership MOR Institutional Ownership NAMS Institutional Ownership AMRX Institutional Ownership This page (NASDAQ:PHAR) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharming Group N.V. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharming Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access